| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | N8Q12KU2SW |
| InChI Key | ZQOBVMHBVWNVBG-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C27H20ClN3O2 |
| Molecular Weight | 453.93 |
| AlogP | 4.98 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 71.09 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 33.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Bcr/Abl fusion protein inhibitor | Other |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Dementia | 2 | D003704 | ClinicalTrials |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4130229 |
| FDA SRS | N8Q12KU2SW |
| Guide to Pharmacology | 11191 |
| PubChem | 89884852 |
| SureChEMBL | SCHEMBL15363815 |